{
    "code": "02018174",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02018174",
    "time": "2016-11-18 19:27:00",
    "許可證字號": "衛署藥輸字第018174號",
    "註銷狀態": "已註銷",
    "註銷日期": "88\/09\/22",
    "註銷理由": "未展延而逾期者",
    "有效日期": "84\/08\/15",
    "發證日期": "79\/08\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201817407",
    "中文品名": "德壽魯素注射劑",
    "英文品名": "DOXORBICIN HYDROCHLORIDE FOR INJECTION &quot;DBL&quot;",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肺癌",
    "劑型": "240乾粉注射劑",
    "包裝": "小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DOXORUBICINHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0906901100  恆振企業有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F020007000  DAVID BULL LABORATORIES",
        "製造廠廠址": "7-23 LEXIA PLACE, MULGRAVE VICTORIA 3170,AUSTRALIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "2",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ]
}